![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)
Articles Tagged: OBGYN
July 31, 2026
A Hidden Cancer, Found in Time: One Patient’s CARE Journey
![69496bfd6e788019170349[1]](https://ambrygen.com/wp-content/uploads/2026/07/69496bfd6e7880191703491.jpeg?quality=75&w=82&h=100&crop=1){kind=small}
Germline genetic testing, also known as hereditary cancer testing, can reveal inherited risks for certain cancers long before symptoms appear. For many patients, this knowledge…
Breast Cancer
Genetic Testing
OBGYN
Tag
December 17, 2025
SMARCA4 Pathogenic Variants: Gynecological Cancer Histories from a Laboratory Tested Cohort
Dr. Adela Rodríguez-Hernández (Dana-Farber Cancer Institute) shares results from a study in Gynecologic Oncology that better characterized cancer patterns among individuals with SMARCA4 gPVs, addressing…
Clinical Research
Genetic Testing
OBGYN
December 10, 2025
From Primary Care to Oncology: Digital Risk Tools in Practice
Dr. Melissa Frey explains the difference between Progeny and the CARE Program in providing patient history, analyzing criteria, and offering genetic testing in an OB-GYN…
Genetic Testing
OBGYN
progeny
October 22, 2025
Progeny Research Spotlight: Uncovering Breast Cancer Risk in the GYN Oncology Clinic
Dr. Melissa Frey applies breast cancer risk models from Progeny and discovers a significant number were also at elevated risk for breast cancer.
Breast Cancer
OBGYN
progeny
September 30, 2025
Progeny Research Spotlight: Transforming Risk Assessment in GYN Oncology
Melissa Frey—a gynecologic oncologist, cancer geneticist, and researcher—discusses the critical importance of early cancer risk assessment and Ambry’s Progeny program.
Genetic Testing
OBGYN
progeny
July 16, 2025
Creating Program Champions: The Power of Staff Education and Ownership in Our High-Risk Women’s Program
Lisa McGuire discusses the importance of the Ambry CARE Program in launching a High-Risk Women’s Program at HCA Florida Ocala
Breast Cancer
OBGYN
